Skip to main content

Becton Dickinson and Company(BDX-N)

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

BD, Accelerate Diagnostics Announce Global Commercial Collaboration

PR Newswire - Mon Aug 15, 5:50AM CDT

Companies will work together to bring rapid antimicrobial identification and susceptibility diagnostics to more clinicians and patients worldwide

FRANKLIN LAKES, N.J. and TUCSON, Ariz., Aug. 15, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Accelerate Diagnostics, Inc. (NASDAQ: AXDX) an innovator of rapid in-vitro diagnostics in microbiology, today announced a worldwide commercial collaboration agreement where BD will offer Accelerate's rapid testing solution for antibiotic resistance and susceptibility offering results in hours, versus one to two days with some traditional laboratory methods.


Provided Content: Content provided by PR Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.